Aarkstore - Migraine

1. Category : Pharmaceuticals and Healthcare Aarkstore - Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

2. Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Migraine. A key objective of DelveInsights report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Migraine. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Migraine. While the leading brands, companies and chemicals are considered thoroughly, DelveInsights report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India. The research analysis also presents the global sales forecasts data till 2016. Browse Complete Report – http://www.aarkstore.com/pharmaceuticals-healthcare/97798/migraine-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2015

3. Data Sources • The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. • Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. • Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

4. Scope • A snapshot of the global Market therapeutics scenario for Migraine. • A review of the marketed products under prescription for Migraine, regulatory information and marketing status. • Coverage of global patent coverage and detailed commentaries on the US patent challenges. • Graphical representation of investigational products for patent expiry and market exclusivities across the globe. • Product profiles for marketed products for Migraine with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. • Coverage of API Manufacturers for Migraine drugs in the United States, Europe and Asian Regions with location details. • Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Migraine drugs.

5. Reasons to buy • Evaluate the marketing status and exclusivity details of Migraine key products to exploit opportunities for generic drug development opportunities. • Identify and understand important and diverse types of therapeutics under Phase III development for Migraine. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Migraine. • API intelligence over marketed drugs for Migraine and gaining primary intelligence over active ingredients manufacturers across the globe. • API intelligence over leading Phase III Pipeline drugs. • Develop and design strategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

6. Table of Content • Indication Overview • Marketed Drugs • Marketed Details of Drugs by Application Type • Marketed Details of Drugs (NDA) by Marketing Status • Marketed Details of Drugs by Patent Expiration Timeline • Active Pharmaceutical Ingredient (API) Manufacturers Assessment • API Manufacturers by United States Drug Master File (US DMF) Status • API Manufacturers by US DMF Status (Drug Specific) • API Manufacturers in Europe by Country • API Manufacturers in India by State • API Manufacturers in China by Province • Marketed Details of Approved Drugs by Geography • Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs

7. List of Tables • Migraine Therapeutic Market, US, Marketed Drugs by Application Type, 2015 • Migraine Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015 • Migraine Therapeutic Market, US, (Year), 2015 • Migraine Marketed Drugs, API Manufacturers by US DMF Status, 2015 • Migraine Marketed Drugs, US DMF Status Drug Specific (Number), 2015 • Migraine Drugs, API Manufacturers, Europe by Country, 2015 • Migraine Drugs, API Manufacturers, India by State, 2015 • Migraine Drugs, API Manufacturers, China by Province, 2015 • Migraine Drugs, API Manufacturers by Geography 2015 • Migraine Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2015 • Migraine Therapeutic Market, Global Sales 2012-2016 (in million USD) • API Manufacturers for Drug, 2015 • Phase III Drugs for Migraine, 2015 • Discontinued Drugs for Migraine, 2015

8. List of Figures • Migraine Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015 • Migraine Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015 • Migraine Therapeutic Market, US, (Year), 2015 • Migraine Marketed Drugs, API Manufacturers by US DMF Status (%), 2015 • Migraine Marketed Drugs, US DMF Status Drug Specific (Number), 2015 • Migraine Drugs, API Manufacturers, Europe by Country, 2015 • Migraine Drugs, API Manufacturers, India by State, 2015 • Migraine Drugs, API Manufacturers, China by Province, 2015 • Migraine Drugs, API Manufacturers by Geography 2015

9. Related reports: • Pharmaceutical Industry Business Confidence Report H1 2015 • Steatohepatitis Global Clinical Trials Review, H1, 2015 • Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015 • Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015 • Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H1, 2015 • Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015 • Patient Monitoring and Diagnostic Systems Markets in China • Hearing Aids Markets in China • Medical Imaging System and Equipment Markets in China • Medical Devices Markets in China

10. Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Published: Feb 2015 | 100 Pages Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Migraine. Price

11. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news